Saturday, August 17, 2024 12:03:34 PM
Perhaps another synergy between RPC and nwbo is their inclination if not full commitment to advancing cancer research and treatments!
Merck is a great BP (full disclosure: I am long) and has a strong commitment to research, however it also has other aspects to consider and drive their decisions and paths to navigate through while not disappointing Wall Street.
There are worse partners and fates than hooking up with Merck, and personally, winding up with a fairly large amount of additional Merck shares (with their dividends) would make for a great retirement asset and legacy for generational wealth.
If you trust LP especially, and LG, to make decisions aligned with the greater good as well as their own good, which is aligned with shareholders by virtue of large share equivalent holdings, our interests are in committed hands and to bring back an old expression, LP plays multidimensional chess!!!
Merck is a great BP (full disclosure: I am long) and has a strong commitment to research, however it also has other aspects to consider and drive their decisions and paths to navigate through while not disappointing Wall Street.
There are worse partners and fates than hooking up with Merck, and personally, winding up with a fairly large amount of additional Merck shares (with their dividends) would make for a great retirement asset and legacy for generational wealth.
If you trust LP especially, and LG, to make decisions aligned with the greater good as well as their own good, which is aligned with shareholders by virtue of large share equivalent holdings, our interests are in committed hands and to bring back an old expression, LP plays multidimensional chess!!!
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
